Skip to content
lifestyle.womensconference.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Zymeworks Inc.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
June 15, 2026
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock
May 15, 2026
Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 8, 2026
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
March 30, 2026
Zymeworks Announces Participation in Upcoming Investor Conferences
March 24, 2026
←
Previous Page
1
2